Fink E, Schill W B, Fiedler F, Krassnigg F, Geiger R, Shimamoto K
Biol Chem Hoppe Seyler. 1985 Sep;366(9):917-24. doi: 10.1515/bchm3.1985.366.2.917.
Samples of human seminal plasma were subjected to gel filtration, and the eluted fractions were analysed for their contents of tissue kallikrein-like antigen, arginine esterase activity and kininogenase activity. Two peaks of tissue kallikrein-like antigen were detected with apparent molecular masses of about 72 and 48 kDa. As judged by the criteria of molecular mass, immunoreactivity, kininogenase activity, identification of the released kinin as kallidin and inhibition studies, a genuine tissue kallikrein has been identified in the 48-kDa peak. In addition, this peak contains one or more species of immunoreactive tissue kallikrein which differ in molecular mass and enzymatic activities. The 72-kDa peak probably represents the complex of tissue kallikrein with alpha 1-proteinase inhibitor rather than a true high molecular mass tissue kallikrein. The prostate gland was identified as the site of origin of the tissue kallikrein in the seminal fluid by indirect methods and by demonstrating immunoreactive tissue kallikrein in prostatic tissue and secretion.
对人精浆样本进行凝胶过滤,并分析洗脱组分中的组织激肽释放酶样抗原含量、精氨酸酯酶活性和激肽原酶活性。检测到两个组织激肽释放酶样抗原峰,其表观分子量约为72 kDa和48 kDa。根据分子量、免疫反应性、激肽原酶活性、释放的激肽鉴定为胰激肽以及抑制研究的标准判断,在48 kDa峰中鉴定出一种真正的组织激肽释放酶。此外,该峰包含一种或多种免疫反应性组织激肽释放酶,它们在分子量和酶活性上有所不同。72 kDa峰可能代表组织激肽释放酶与α1-蛋白酶抑制剂的复合物,而不是真正的高分子量组织激肽释放酶。通过间接方法以及在前列腺组织和分泌物中证明免疫反应性组织激肽释放酶,确定前列腺是精液中组织激肽释放酶的来源部位。